Annual Report 2007

Annual Report 2007 年報 45 Note 1: Mr Li Tyson Sandy Ying Lun, resigned as a director on 30 September 2007 and therefore, had not attended the meetings which were held after 30 September 2007. Note 2: Mr Michael David Ricks, was appointed as a director on 30 September 2007 and therefore, did not attend the meetings which were held prior to 30 September 2007. Directors are consulted to include matters in the agenda for regular Board meetings. Dates of regular Board meetings are scheduled at least 14 days in advance to provide sufficient notice to give all Directors an opportunity to attend. For all other Board meetings, reasonable notice will be given. Nomination Committee The Company has established a Nomination Committee with written terms of reference. The Nomination Committee comprises of 3 members, namely, Dr Dick Mei Chang and Dr Liu Xu (both are independent non-executive Directors) and Mr Wang (an executive Director). Dr. Chang was appointed as the chairman of the Nomination Committee. The principal roles and functions of the Nomination Committee include: (a) to review the structure, size and composition of the Board on a regular basis and make recommendations to the Board regarding any proposed changes; (b) to identify individuals suitably qualified to become Board members and select or make recommendations to the Board on the selection of individuals nominated for directorship; (c) to assess the independence of independent non-executive directors with regard to the requirements under the Listing Rules; and (d) to make recommendations to the Board on relevant matters related to the appointment or re-appointment of directors and succession planning for directors in particular the Chairman and the Chief Executive Officer. The Nomination Committee held the first meeting on 6 April 2008 with the presence of all members to review the size, structure and composition of the Board and made its recommendations to the Board on the appointment of a member of Audit Committee and the re-appointment of Directors whom are subject to retirement by rotation and eligible for re-election at the forthcoming annual general meeting, and assessment of independence of Independent Non-executive Directors. 附註 1 ：李英倫先生於二零零七年九月三十日辭任董事， 故並無出席二零零七年九月三十日後舉行的會 議。 附註 2 ： Michael David Ricks 先生於二零零七年九月三十 日獲委任為董事，故並無出席二零零七年九月 三十日前舉行的會議。 會向各董事諮詢須列入董事會常規會議議程的 事項。董事會常規會議的日期須於召開前最少 14 日前落實，以充裕通知全體董事安排出席會 議，而所有其他董事會議則會作出合理通知。 提名委員會 本公司已成立提名委員會，並訂有書面職責條 款。提名委員會由 3 名成員組成，包括獨立非 執行董事張未博士與劉旭博士以及執行董事王 先生。張博士獲委任為提名委員會主席。 提名委員會之主要工作及職能包括下列各項﹕ (a) 定期檢討董事會之架構、人數及組合， 並就任何擬作出之變動向董事會提出建 議； (b) 物色具備合適資格可擔任董事會成員之 人士，並挑選提名有關人士出任董事或 就此向董事會提供意見； (c) 根據上市規則之規定，評核獨立非執行 董事之獨立性；及 (d) 就委任或續聘董事以及董事（尤其是主席 及行政總裁）繼任計劃之有關事宜向董事 會提出建議。 提名委員會於二零零八年四月六日舉行第一次 會議，全體成員均有出席有關會議。會上，提 名委員會檢討董事會之人數、架構及組合，並 就委任審計委員會成員及續聘須於應屆股東週 年大會輪值告退並膺選連任之董事等事宜向董 事會提供意見，及就獨立非執行董事之獨立性 作評估。